Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...

Inspire Fund provides funding for projects that engage underserved communities with the topic of brain health and reducing the risk of dementia. This scheme is part of Alzheimer’s Research UK’s work ...